Literature DB >> 25266797

The expression profiles of microRNAs in Kaposi's sarcoma.

Xiu-Juan Wu1, Xiong-Ming Pu, Zong-Feng Zhao, Ya-Nan Zhao, Xiao-Jing Kang, Wei-Dong Wu, Yun-Min Zou, Cao-Ying Wu, Yuan-Yuan Qu, De-Zhi Zhang, Yan-Yan Feng, Jian-Yong Liu.   

Abstract

Kaposi's sarcoma (KS) is a multicentric angioproliferative tumor of mesenchymal origin. The molecular and biologic aspects of KS are not fully understood. MicroRNAs are non-protein-coding small RNAs in the size range 19-25 nucleotides (nt) that play important roles in biological processes, including cellular differentiation, proliferation, and death. We performed a miRNA microarray analysis by detecting six paired KS and matched adjacent healthy tissues using the 7th generation of miRCURY(TM) LNA Array (v.18.0) (Exiqon) containing 3100 capture probes. We selected 10 significant differentially expressed miRNAs, which were confirmed by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) in 18 paired KS and matched adjacent healthy tissue specimens. We also investigated the associations between clinical features and miRNA expression. Among the 3100 human miRNA probes in the microarrays, we identified 170 differentially expressed miRNAs (69 upregulated and 101 downregulated miRNAs) in KS versus adjacent healthy tissues. Among the most significantly upregulated miRNAs were miR-126-3p, miR-199a-3p, miR-16-5p, and the 13 KSHV-related miRNAs. The most significantly downregulated miRNAs included miR-125b-1-3p and miR-1183. Eight upregulated miRNAs, miR-181b-5p, miR-199a-3p, miR-15a-5p, miR-126-3p, miR-1297, kshv-miR-k12-12-3p, kshv-miR-k12-1-5p, and miR-16-5p, and two downregulated miRNAs, miR-125b-1-3p and miR-1183, were confirmed by qRT-PCR in 18 paired KS samples. The qRT-PCR results for 10 miRNAs were consistent with our microarray results. The miR-125b-1-3p and miR-16-5p had statistically significant associations with HHV-8 and HIV infections in KS. The results of miRNA profiling showed that KS appears to have unique expression patterns when compared with paired adjacent healthy tissues, suggesting that deregulation of miRNAs plays an important role in the progression of KS. These differentially expressed miRNAs may provide novel diagnostic and prognostic tools.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25266797     DOI: 10.1007/s13277-014-2626-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  MicroRNA expression profiles in Kaposi's sarcoma.

Authors:  Ana Maria Catrina Ene; Ioana Borze; Mohamed Guled; Mariana Costache; Gayle Leen; Maria Sajin; Elena Ionica; Aura Chitu; Sakari Knuutila
Journal:  Pathol Oncol Res       Date:  2013-09-13       Impact factor: 3.201

Review 3.  How do microRNAs regulate gene expression?

Authors:  Richard J Jackson; Nancy Standart
Journal:  Sci STKE       Date:  2007-01-02

Review 4.  Principles of micro-RNA production and maturation.

Authors:  Y Zeng
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

Review 5.  Small non-coding RNAs in animal development.

Authors:  Giovanni Stefani; Frank J Slack
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

6.  Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.

Authors:  Debasmita Roy; Dirk P Dittmer
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

7.  miRNAs can increase the efficiency of ex vivo platelet generation.

Authors:  Stephan Emmrich; Kerstin Henke; Jan Hegermann; Matthias Ochs; Dirk Reinhardt; Jan-Henning Klusmann
Journal:  Ann Hematol       Date:  2012-07-05       Impact factor: 3.673

8.  Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

Authors:  Hsei-Wei Wang; Matthew W B Trotter; Dimitrios Lagos; Dimitra Bourboulia; Stephen Henderson; Taija Mäkinen; Stephen Elliman; Adrienne M Flanagan; Kari Alitalo; Chris Boshoff
Journal:  Nat Genet       Date:  2004-06-27       Impact factor: 38.330

9.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  Reference miRNAs for miRNAome analysis of urothelial carcinomas.

Authors:  Nadine Ratert; Hellmuth-Alexander Meyer; Monika Jung; Hans-Joachim Mollenkopf; Ina Wagner; Kurt Miller; Ergin Kilic; Andreas Erbersdobler; Steffen Weikert; Klaus Jung
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

View more
  25 in total

1.  Expression of MicroRNAs miR-145, miR-181c, miR-199a and miR-1183 in the Blood and Hippocampus of Patients with Mesial Temporal Lobe Epilepsy.

Authors:  Luana Grupioni Lourenço Antônio; Priscila Freitas-Lima; Gabriela Pereira-da-Silva; João Alberto Assirati; Caio Marconato Matias; Mucio Luiz Assis Cirino; Luis Fernando Tirapelli; Tonicarlo Rodrigues Velasco; Americo Ceiki Sakamoto; Carlos Gilberto Carlotti; Daniela Pretti da Cunha Tirapelli
Journal:  J Mol Neurosci       Date:  2019-07-31       Impact factor: 3.444

Review 2.  KSHV microRNAs: Tricks of the Devil.

Authors:  Jie Qin; Wan Li; Shou-Jiang Gao; Chun Lu
Journal:  Trends Microbiol       Date:  2017-03-02       Impact factor: 17.079

Review 3.  MicroRNA-224: as a potential target for miR-based therapy of cancer.

Authors:  Wei Chen; Xue-Mei Fan; Ling Mao; Jun-Ying Zhang; Jian Li; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-08-08

4.  miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.

Authors:  M Braoudaki; G I Lambrou; K Giannikou; S A Papadodima; A Lykoudi; K Stefanaki; G Sfakianos; A Kolialexi; F Tzortzatou-Stathopoulou; M Tzetis; S Kitsiou-Tzeli; E Kanavakis
Journal:  Tumour Biol       Date:  2016-01-26

5.  MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia.

Authors:  Dan Chen; Dijiong Wu; Keding Shao; Baodong Ye; Jian Huang; Yanting Gao
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

6.  Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2.

Authors:  Soo Mi Lee; Kenneth M Kaye; Frank J Slack
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-09       Impact factor: 11.205

7.  Use of X-Chromosome Inactivation Pattern to Analyze the Clonality of 14 Female Cases of Kaposi Sarcoma.

Authors:  Ding Yuan; Wu XiuJuan; Zhang Yan; Liang JunQin; Xiang Fang; Yu Shirong; Kang Xiaojing; Feng Yanyan; Wu Weidong; Luo Dong; Lu Qingli; Zhang DeZhi; Pu XiongMing
Journal:  Med Sci Monit Basic Res       Date:  2015-06-16

8.  A Non-Coding RNA Network Involved in KSHV Tumorigenesis.

Authors:  Julián Naipauer; Martín E García Solá; Daria Salyakina; Santas Rosario; Sion Williams; Omar Coso; Martín C Abba; Enrique A Mesri; Ezequiel Lacunza
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

9.  A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling.

Authors:  Minmin Hu; Cong Wang; Wan Li; Weiping Lu; Zhiqiang Bai; Di Qin; Qin Yan; Jianzhong Zhu; Brian J Krueger; Rolf Renne; Shou-Jiang Gao; Chun Lu
Journal:  PLoS Pathog       Date:  2015-09-24       Impact factor: 6.823

10.  Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.

Authors:  Preethi Krishnan; Sunita Ghosh; Bo Wang; Dongping Li; Ashok Narasimhan; Richard Berendt; Kathryn Graham; John R Mackey; Olga Kovalchuk; Sambasivarao Damaraju
Journal:  BMC Genomics       Date:  2015-09-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.